The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties.

1. The 5-hydroxytryptamine (5-HT3) receptor antagonist, GR 38032F, which possesses potent anti-emetic properties in vomiting induced by cancer chemotherapeutic drugs, has been tested to determine its value in the prophylaxis of motion sickness induced by cross-coupled stimulation. The double-blind trial compared GR 38032F with both a placebo (lactose) and with hyoscine. In addition, studies of ocular pursuit and saccadic eye movements were carried out following the administration of each drug. 2. The prophylactic effect of GR 38032F on motion-induced nausea was indistinguishable from that of placebo, whereas following hyoscine subjects showed a highly significant (P less than 0.001) increase in tolerance to cross-coupled stimulation. Tests of oculomotor function showed no effect on saccadic eye movement from either drug. However, both drugs produced a significant (P less than 0.05) though small reduction in eye velocity gain during pursuit eye movement. 3. These findings suggest that the 5-HT3 receptor is not involved in the neural pathways that bring about motion sickness, but that it may have a role in the control of ocular pursuit. The absence of an anti-motion sickness effect from a drug that is effective in the treatment of vomiting induced by cancer chemotherapy serves to emphasize that different neural mechanisms are involved in the generation of motion sickness.

[1]  L. Optican,et al.  Cerebellar-dependent adaptive control of primate saccadic system. , 1980, Journal of neurophysiology.

[2]  J. Kanto,et al.  Saccadic eye movements in determination of the residual effects of flunitrazepam. , 2009, Acta pharmacologica et toxicologica.

[3]  J. Reason.  Relations between motion sickness susceptibility, the spiral after-effect and loudness estimation. , 1968, British journal of psychology.

[4]  G. Barnes,et al.  Predictive velocity estimation in the pursuit reflex response to pseudo‐random and step displacement stimuli in man. , 1987, The Journal of physiology.

[5]  I. Lancranjan,et al.  FIRST RESULTS WITH ICS 205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS , 1987, The Lancet.

[6]  A Graybiel,et al.  A provocative test for grading susceptibility to motion sickness yielding a single numerical score. , 1970, Acta oto-laryngologica. Supplementum.

[7]  R W Baloh,et al.  Effect of alcohol and marijuana on eye movements. , 1979, Aviation, space, and environmental medicine.

[8]  H. Borison,et al.  Emetic action of xylazine on the chemoreceptor trigger zone for vomiting in cats. , 1981, Journal of veterinary pharmacology and therapeutics.

[9]  K. Davis,et al.  CKholinergic mechanisms and anterior pituitary hormone secretion. , 1980, Biological psychiatry.

[10]  E. Kirsten,et al.  Characteristics and response differences to iontophoretically applied norepinephrine, D-amphetamine and acetylcholine on neurons in the medial and lateral vestibular nuclei of the cat , 1976, Brain Research.

[11]  D. Robinson.  The mechanics of human saccadic eye movement , 1964, The Journal of physiology.

[12]  L. Stark,et al.  The main sequence, a tool for studying human eye movements , 1975 .

[13]  A. T. Smith,et al.  The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration. , 1981, British journal of clinical pharmacology.

[14]  R. Eckmiller.  Neural control of pursuit eye movements. , 1987, Physiological reviews.

[15]  I. M. Wilkinson,et al.  The influence of drugs and alcohol upon human eye movement. , 1976, Proceedings of the Royal Society of Medicine.

[16]  B. Costall,et al.  5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesis , 1986, Neuropharmacology.

[17]  G. Barnes.  A procedure for the analysis of nystagmus and other eye movements. , 1981, Aviation, space, and environmental medicine.

[18]  A Graybiel,et al.  Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. , 1968, Aerospace medicine.

[19]  John H. R. Maunsell,et al.  The effect of frontal eye field and superior colliculus lesions on saccadic latencies in the rhesus monkey. , 1987, Journal of neurophysiology.

[20]  R L Kohl.  Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration. , 1987, Aviation, space, and environmental medicine.

[21]  B. Cohen,et al.  Coding of information about rapid eye movements in the pontine reticular formation of alert monkeys , 1976, Brain Research.

[22]  R. Coombes,et al.  PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST , 1987, The Lancet.

[23]  G. H. Crampton,et al.  Buspirone blocks motion sickness and xylazine-induced emesis in the cat. , 1987, Aviation, space, and environmental medicine.

[24]  A Edge,et al.  The effects of ethanol on visual-vestibular interaction during active and passive head movements. , 1985, Aviation, space, and environmental medicine.